Nerivio For
Veterans

Did you know?

Veterans are more likely to experience migraine than civilians[1]

Veterans returning home from Iraq and Afghanistan have two to four times the incidence of migraine as compared to the general population [2]

Get Nerivio from your VA Medical Provider
Prescribe Nerivio using this form. Available also via e-prescription*
1
Send the prescription to ProCare Rx
2
ProCare Rx will deliver Nerivio directly to your patient
3
Nerivio really helped me!
Nerivio

For Teens

FDA
Approved
Treat &
Prevent
Ages
8 & Up

How to get the Nerivio REN wearable from your VA Healthcare Provider

*If not enrolled in the VA system contact by visiting www.va.gov/healthbenefits/enroll or by calling 1-877-222-VETS (1-877-222-8387)

Prescribe Nerivio using this form. Available also via e-prescription*
1
Send the prescription to ProCare Rx
2
ProCare Rx will deliver Nerivio directly to your patient
3

Make an appointment with your VA Healthcare Provider. You may be required to get a referral to your closest VA neurologist

Speak to your VA provider to see if Nerivio is right for you

Your Nerivio device will be available either at your VA or mailed to your home

Upon receiving your Nerivio, you are welcome to contact the Nerivio Cares Team with any questions Monday-Friday between 8 am and 8 pm ET at 937-637-4846 or support@nerivio.com

High five for freedom from medication complications and side effects

Drug-free and non-addictive
No systemic side effects
No pills, no needles
No risk of overuse
Use alone or alongside medication 

Drug-free, easy-to-use, non-invasive wearable device to treat and prevent migraine

Effective

66.7% of patients  found relief from their migraine pain at 2 hrs post treatment.(3)
4 migraine days reduction when used every other day.(5)

Safe

96.4% of patients studied did not report any device related side effects.(3) 0 device-related adverse events reported in pivotal prevention trial. (5)

Easy to Use

89.7% of patients opted to treat with REN (Nerivio) to avoid medication use.(4)

Prescribe Nerivio using this form. Available also via e-prescription*
1
Send the prescription to ProCare Rx
2
ProCare Rx will deliver Nerivio directly to your patient
3
How Nerivio Works
Ensure effective treatment
Text NERIVIO to 866-637-4846 to receive the Nerivio App.
For assistance activating your device or for any technical questions, contact Nerivio Cares Customer Support at 1-937-NERIVIO (937-637-4846) or support@nerivio.com

Sources

Nerivio is indicated for acute and/or preventive treatment of migraine with or without aura in patients 8 years of age or older. It is a prescription use, self-administered device for use in the home environment at the onset of migraine headache or aura for acute treatment, or every other day for preventive treatment. Nerivio should not be used by people with uncontrolled epilepsy, an active implantable medical device, such as a pacemaker, hearing aid implant, or any implanted electronic device. Such use could cause electric shock, electrical interference or serious injuries or medical conditions. Nerivio has not been evaluated in people with congestive heart failure (CHF), severe cardiac or cerebrovascular disease, for pregnancy, or those under the age of 8. Nerivio should only be applied on the upper arm over dry, healthy skin with normal physical sensation and without any metallic implants or in proximity to cancerous lesions. For full user instructions and safety information, please see the Nerivio User Manual.

‍

    1. https://americanmigrainefoundation.org/resource-library/veterans-and-migraine/
    2. GBD 2016 Headache Collaborators. Global, regional, and national burden of migraine and tension-type headache, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet Neurol. 2018;17(11):954-976. doi:10.1016/S1474-4422(18)30322-3
    3. Yarnitsky D, Dodick DW, Grosberg BM, Burstein R, Ironi A, Harris D, Lin T, Silberstein SD. Remote Electrical Neuromodulation (REN) Relieves Acute Migraine: A Randomized, Double-Blind, Placebo-Controlled, Multicenter Trial. Headache. 2019;59(8): 1240-1252
    4. Marmura MJ, Lin T, Harris D, lroni A, Rosen NL. Incorporating Remote Electrical Neuromodulation (REN) Into Usual Care Reduces Acute Migraine Medication. Use: An Open-Label Extension Study. Frontiers in Neurology. 2020; 11 :226
    5. Tepper SJ, et al. Remote electrical neuromodulation for migraine prevention: A double-blind, randomized, placebo-controlled clinical trial. Headache. 2023. doi: 10.1111/head.14469.

‍